Revive Therapeutics(RVVTF)
$0.01-0.00 (-16.67%)
RVVTF
Revive Therapeutics financials statements
$0.01
At close:-0.00 (-16.67%)
Revive Therapeutics (RVVTF) Income Statement
58 Followers
Revive Therapeutics Income Statement
Last quarter (Q4 2026), Revive Therapeutics's total revenue was C$0.00. In Q4, Revive Therapeutics's net income was C$3.33K. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -189.00 | C$ -248.00 | C$ -328.00 | C$ -434.00 | C$ -578.00 | |
| C$ 1.05M | C$ 1.65M | C$ 3.29M | C$ 5.52M | C$ 17.83M | |
| Depreciation and Amortization | C$ 189.00 | C$ 248.00 | C$ 328.00 | C$ 434.00 | C$ 578.00 |
| C$ -1.05M | C$ -11.01M | C$ -5.60M | C$ -5.52M | C$ -17.74M | |
| C$ -1.05M | C$ -1.65M | C$ -3.29M | C$ -5.52M | C$ -17.83M | |
| C$ 30.84K | C$ -9.36M | C$ -2.33M | C$ -796.15K | C$ 26.10K | |
| C$ -1.02M | C$ -11.01M | C$ -5.62M | C$ -6.32M | C$ -17.81M | |
| C$ -1.02M | C$ -11.01M | C$ -5.62M | C$ -6.32M | C$ -17.83M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.00 | C$ -0.03 | C$ -0.01 | C$ -0.02 | C$ -0.06 |
| Diluted EPS | C$ -0.00 | C$ -0.03 | C$ -0.01 | C$ -0.02 | C$ -0.06 |
| Weighted Average Shares Outstanding | 434.07M | 419.71M | 380.48M | 339.37M | 319.76M |
| Weighted Average Shares Outstanding (Diluted) | 434.07M | 419.71M | 380.48M | 339.37M | 319.76M |
Currency in CAD

